Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assuring the patient centeredness of patient-reported outcomes: content validity in medical product development and comparative effectiveness research.

Literature DB >> 22152164

Assuring the patient centeredness of patient-reported outcomes: content validity in medical product development and comparative effectiveness research.

Ethan Basch, Amy P Abernethy, Bryce B Reeve.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2011 PMID： 22152164 PMCID： PMC4319699 DOI： 10.1016/j.jval.2011.10.002

Source DB: PubMed Journal: Value Health ISSN： 1098-3015 Impact factor: 5.725

× No keyword cloud information.

6 in total

1. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Authors: Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal: Value Health Date: 2011-10-10 Impact factor: 5.725

2. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

Authors: Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal: Value Health Date: 2011-10-13 Impact factor: 5.725

3. The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.

Authors: Thomas M Atkinson; Tito R Mendoza; Laura Sit; Steven Passik; Howard I Scher; Charles Cleeland; Ethan Basch
Journal: Pain Med Date: 2010-01-15 Impact factor: 3.750

Review 4. Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting.

Authors: Susan Magasi; Gery Ryan; Dennis Revicki; William Lenderking; Ron D Hays; Meryl Brod; Claire Snyder; Maarten Boers; David Cella
Journal: Qual Life Res Date: 2011-08-25 Impact factor: 4.147

5. Use of the McGill pain questionnaire in the assessment of cancer pain: replicability and consistency.

Authors: Charles Graham; Susan S Bond; Mary M Gerkovich; Mary R Cook
Journal: Pain Date: 1980-06 Impact factor: 6.961

6. Evaluation of item candidates: the PROMIS qualitative item review.

Authors: Darren A DeWalt; Nan Rothrock; Susan Yount; Arthur A Stone
Journal: Med Care Date: 2007-05 Impact factor: 2.983

6 in total

1. On the validity of measuring change over time in routine clinical assessment: a close examination of item-level response shifts in psychosomatic inpatients.

Authors: S Nolte; A Mierke; H F Fischer; M Rose
Journal: Qual Life Res Date: 2015-09-09 Impact factor: 4.147

Review 2. Recommendations for evaluation of neurogenic bladder and bowel dysfunction after spinal cord injury and/or disease.

Authors: Denise G Tate; Tracey Wheeler; Giulia I Lane; Martin Forchheimer; Kim D Anderson; Fin Biering-Sorensen; Anne P Cameron; Bruno Gallo Santacruz; Lyn B Jakeman; Michael J Kennelly; Steve Kirshblum; Andrei Krassioukov; Klaus Krogh; M J Mulcahey; Vanessa K Noonan; Gianna M Rodriguez; Ann M Spungen; David Tulsky; Marcel W Post
Journal: J Spinal Cord Med Date: 2020-03 Impact factor: 1.985

Assuring the patient centeredness of patient-reported outcomes: content validity in medical product development and comparative effectiveness research.

1. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

2. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

3. The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.

Review 4. Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting.

5. Use of the McGill pain questionnaire in the assessment of cancer pain: replicability and consistency.

6. Evaluation of item candidates: the PROMIS qualitative item review.

1. On the validity of measuring change over time in routine clinical assessment: a close examination of item-level response shifts in psychosomatic inpatients.

Review 2. Recommendations for evaluation of neurogenic bladder and bowel dysfunction after spinal cord injury and/or disease.

Review 3. Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials.

Review 4. Need for Digital Biomarkers in Musculoskeletal Trials.

5. Ophthalmology Patient Perceptions of Open Payments Information.

6. Maintaining primacy of the patient perspective in the development of patient-centered patient reported outcomes.